Back to Search
Start Over
In Vitro Pharmacological Characterization of CRN04894: The First Reported Oral, Selective Nonpeptide Melanocortin 2 Receptor Antagonist Evaluated in Phase 1 First‐in‐Human Clinical Trials
- Source :
- The FASEB Journal. 36
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Genetics
Molecular Biology
Biochemistry
Biotechnology
Subjects
Details
- ISSN :
- 15306860 and 08926638
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- The FASEB Journal
- Accession number :
- edsair.doi...........3ed6884c1b803d0e99d7697c6b9ebd9b
- Full Text :
- https://doi.org/10.1096/fasebj.2022.36.s1.r2027